Overview

PaNeX: Partial Nephrectomy Under Xenon

Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
0
Participant gender:
All
Summary
Purpose of this study is to determine whether Xenon - as compared to Isoflurane - shows a nephroprotection after partial nephrectomy.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
RWTH Aachen University
Collaborator:
German Research Foundation
Treatments:
Anesthetics
Isoflurane
Xenon
Criteria
Inclusion Criteria:

- Patients willing and able to complete the requirements of this study

- Patients with renal carcinoma restricted to one kidney

- Patients undergoing partial nephrectomy

- Men and women >= 18 yrs

- Informed consent

Exclusion Criteria:

- Chronic renal failure with a GFR < 60ml/min/1,73m2 body surface area

- American Society of Anesthesiologists (ASA)>III

- Hypersensitivity to the study anaesthetics

- Chronic obstructive pulmonary disease (COPD) GOLD IV

- Acute coronary syndrome during the last 24 hours; haemodynamic instability,
requirement of inotropic support

- Severe cardial dysfunction New York Heart Association (NYHA) >III

- Disabling neuropsychiatric disorders

- Increased intracranial pressure

- pregnant or breastfeeding women

- Women of childbearing potential

- Presumed uncooperativeness or legal incapacity

- Lack of informed consent

- Participation in a concomitant trial within the last 30 days